Rankings
▼
Calendar
OABI Q2 2024 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena
OABI
OmniAb, Inc.
$231M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
+9.6% YoY
Gross Profit
$8M
100.0% margin
Operating Income
-$16M
-214.1% margin
Net Income
-$14M
-179.0% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
+100.3%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$13M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$337M
Total Liabilities
$43M
Stockholders' Equity
$294M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$7M
+9.6%
Gross Profit
$8M
$2M
+265.0%
Operating Income
-$16M
-$19M
+15.5%
Net Income
-$14M
-$15M
+7.4%
Revenue Segments
Service
$4M
93%
Royalty
$318,000
7%
← FY 2024
All Quarters
Q3 2024 →